Tizona Therapeutics, Inc.

Tizona Therapeutics is a clinical-stage, privately-held immunotherapy company committed to developing first-in-class therapies that deliver transformational benefits for people with cancer. Their mission is to translate novel scientific insights into immunotherapies that stimulate the immune system and counter immune suppression. They have a robust pipeline of promising therapies, including TTX-080, a first-in-class anti-HLA-G antibody, which is currently in a Phase 1 clinical trial. Tizona is committed to improving outcomes for patients with cancer by leveraging their scientific expertise and strategic partnerships.

Tizona has established significant collaborations with industry leaders, including AbbVie and Gilead Sciences, which have provided substantial funding and strategic support for their research and development efforts. Their collaborations have enabled them to advance their pipeline through clinical development and toward potential commercialization. Tizona’s strong focus on innovation and scientific rigor, coupled with their commitment to patient-centric outcomes, positions them as a key player in the rapidly evolving field of immunotherapy.

Tizona Therapeutics does not specifically mention any job flexibility options or policies on their website.

Tizona Therapeutics, Inc. fosters a science-driven, creative, and respectful corporate culture that values excellence and informed risk-taking. They strive to attract and retain the best talent by providing competitive compensation and benefits, including a comprehensive health insurance plan, dental and vision coverage, life insurance, disability insurance, paid time off, and a 401(k) plan.

Tizona Therapeutics is a privately held, clinical-stage immunotherapy company dedicated to developing first-in-class medicines that deliver transformational benefits for people with cancer. Tizona translates scientific breakthroughs into therapeutics that stimulate the immune system and counter immune suppression, ultimately aiming to improve outcomes for patients with cancer by changing the course of cancer progression and relapse.

Tizona Therapeutics fosters a science-driven, creative, and collaborative work environment where dedication, excellence, and informed risk-taking are valued. They emphasize transparency, respect, and a patient-centric approach, creating a culture that encourages open communication, learning from one another, and a shared commitment to improving treatment outcomes for people with cancer.

Tizona Therapeutics is committed to fostering a diverse, equitable, and inclusive workplace, believing that this is essential for driving innovation and achieving their mission. They actively seek to hire and retain individuals from diverse backgrounds, creating an environment where all voices are heard and valued. Tizona strives to provide equal opportunities for all employees, regardless of race, gender, sexual orientation, religion, or disability. Their dedication to DEI is reflected in their company values, which include embracing diversity, encouraging open and honest communication, and promoting an environment that fosters excellence.